SECTION I · THE BRIEF
Brief #03577Updated 31 AUG 2026CAMBRIDGE, MALeverMEDICAL ORGANIZATIONS
Employbl Company Profile

Engineer, Downstream Process Development & MSAT

Scholar Rock is discovering and developing a new class of biologic therapies

Location
Cambridge, MA
Company size
50–200
Posted
Today
Via
Lever
Section II · Full ProfileFree with an account
  • 01Comp band & equity packageLocked
  • 02Seniority & experience requirementsLocked
  • 03Interview process & rubricLocked
  • 04Hiring manager & team contextLocked
  • 05Growth trajectory in this roleLocked
  • 06Offer & decision timelineLocked

Free account · no card · 2 minutes

Scholar Rock logo

Engineer, Downstream Process Development & MSAT · Scholar Rock

View company profile
Job title
Engineer, Downstream Process Development & MSAT
Job location
Cambridge, MA
Job description
Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the Company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. Scholar Rock works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more at ScholarRock.com and follow @ScholarRock on X and on LinkedIn.
Summary of Position:

The Technical Operations Department at Scholar Rock is seeking a scientifically curious and motivated engineer in the Downstream PD & MSAT group. The successful candidate is expected to be proficient in all aspects of the purification process and be comfortable working with a multifunctional team. Experience in late-stage process development and support of external manufacturing is preferred. The selected candidate will work alongside in-house scientists to advance existing projects through the development lifecycle and transfer to CMOs.

Proficiency in AKTA operation, TFF, VRF, JMP for data trending and presentation, and design of experiment skills are key traits that will ensure success in this role.

Position Responsibilities
  • Support external manufacturing of clinical and commercial assets
  • Own and maintain process monitoring databases (CPV and lot history)
  • Support manufacturing campaign readiness review process
  • Drive batch production record review processes
  • Author and drive Downstream change control implementation
  • Work closely with CDMO to support tech transfer and manufacturing activities
  • Technical presentation to greater TechOps team
  • Support process development experiments to develop, optimize, and characterize purification processes for antibodies.
  • Detailed documentation of all experimental studies
  • Candidate Requirements
  • Educational background in Chemical Engineering, Biochemistry, Biotechnology, or related biological Sciences.
  • Direct experience working with mAbs is preferred, and MSAT experience is highly desirable
  • BS with 6+ years of experience
  • MS with 4+ years of experience
  • Ph.D. with 0-2 years of experience
  • View job listing ↗
    The Saturday Briefing

    Get the Saturday tech briefing

    New company profiles, funding moves, and who’s hiring across the market — every Saturday morning.

    Scholar Rock headquarters

    Cambridge, MA

    Company size

    50200 employees

    Founded

    2012

    Total raised

    $843,000,000

    View company profile ↗

    Funding rounds

    • Post Ipo Debt$100M
    • Post Ipo Equity$300M
    • Post Ipo Equity$85M
    • Post Ipo Equity$205M
    • Post Ipo Debt$50M
    • IPOUndisclosed
    • Series C$47M
    • Series B$36M
    • Series A$20M